ARLINGTON, Va.— With the newly authorized Johnson & Johnson vaccine rolling out across the country and President Biden pledging to provide enough vaccines for every adult American by the end of May, healthcare distributors continue to play a central role in the nation’s vaccination efforts.

This week, HDA and its members shared their perspective on these milestones and reaffirmed their commitment to building upon existing partnerships with federal, state and local governments to ensure all Americans have access to a COVID-19 vaccine.

• On March 1, McKesson began distributing the Johnson & Johnson COVID-19 vaccine to communities across the country, in coordination with supply chain partners. Go behind the scenes with Team McKesson to learn about the complex logistics needed to pick, pack and ship the COVID-19 vaccine — safely, efficiently and quickly.
• AmerisourceBergen Chairman, President and CEO Steve Collis joined CNBC’s Squawk on the Street on March 2 to discuss the continued strength and resilience of the healthcare supply chain during COVID-19 and overcoming the challenges with the increased vaccine supply.
• HDA President and CEO Chip Davis reflected on the central role HDA members are playing as the COVID-19 vaccination campaign accelerates in a March 1blog post. In a statement following the FDA’s February 27 authorization of the Johnson & Johnson COVID-19 vaccine, Davis also called attention to healthcare distributors’ capacity, infrastructure and customer networks to move billions of products, including COVID-19 vaccines, to where they are most needed.